Christine Siu - Jun 12, 2024 Form 4 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Role
Director
Signature
/s/ Markus Warmuth, Attorney-in-Fact
Stock symbol
GLUE
Transactions as of
Jun 12, 2024
Transactions value $
$0
Form type
4
Date filed
6/13/2024, 04:30 PM
Previous filing
Jun 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLUE Stock Option (Right to Buy) Award $0 +22.1K $0.00 22.1K Jun 12, 2024 Common Stock 22.1K $4.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 12, 2025 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time.